Sensai
Reading the tape…Pulling live market data…Setting the scene…
Sensai
AI Stock Dissection
AI Stock Dissection
LALPATHLAB
Mr. Shankha Banerjee · Gurugram, India · 5,206 employees
₹1,882.50
▲+4.28%LALPATHLAB is trading near its 52-week high amid strong revenue growth and positive analyst sentiment, though at a premium valuation.
Exchange
NSI
Currency
INR
Day range
₹1,802.00 – ₹1,893.60
52-week range
₹1,272.60 – ₹1,894.90
Sector
Healthcare
Industry
Diagnostics & Research
AI investment rating
AI analysis75% confidence
The stock appears overvalued based on its high P/E ratio of 58.26, though premium may be justified by strong revenue growth and market leadership.
0.7% below the 1-year high · trend up
Hedge-fund memo
Today
The stock is up 4.28%, trading near its 52-week high, indicating strong buying interest.
This week
Continued momentum as the stock remains in the upper range of its recent trading activity.
This month
The stock has shown consistent upward movement, reflecting positive market sentiment.
Bull thesis
Bear thesis
Hidden risks
News & sentiment
Bullish
8 headlines · 4 outlets · 7d
Tone · daily average
Smart money
Named holders aren't published for this listing (common for Indian stocks). The split at left is live.
Financial health
Profitability
Growth
Balance sheet
Financial statements
Earnings intelligence
Beat estimates in 1 of 4 recent quarters (EPS actual vs. consensus).
10.13 vs 11.01273
-8.02% surprise
8.44 vs 7.42
13.75% surprise
6.7331 vs 6.825
-1.35% surprise
Competitive landscape
| Company | Market cap | P/E | ROE | Op. margin | Rev. growth |
|---|---|---|---|---|---|
| LALPATHLAB | 314.34B | 58.26 | — | 25.46% | 19.10% |
| METROPOLIS | 121.35B | 63.82 | 13.37% | 16.51% | 23.00% |
| ALKEM | 695.45B | 30.25 |
Technical intelligence
Volume
RSI (14) · 70 overbought / 30 oversold
MACD (12,26,9) · MACD vs signal
Candlesticks, volume, RSI and MACD from 500sessions of real Yahoo daily data. Moving averages use full history, so they're accurate at the left edge. Support / resistance are the 52-week low / high. Educational — technical signals are not buy or sell calls.
Risk intelligence
Increased competition from other diagnostic chains
Mitigation: Continued investment in technology and service quality to maintain differentiation
Regulatory changes affecting pricing or operations
Mitigation: Strong compliance framework and proactive engagement with regulatory bodies
Business intelligence
Competitive moat
Extensive network of laboratories and collection centers across India provides significant scale advantages and brand recognition.
Supply chain
Upstream (inputs / suppliers)
↓
Downstream (customers / markets)
M&A / strategic moves
Catalyst calendar
Expansion of specialized diagnostic services
Potential entry into new geographic markets
Thesis builder
Bull case
The company continues to expand its network and service offerings, maintaining leadership in the Indian diagnostic market.
Base case
Revenue growth stabilizes around 15-18% annually as market penetration increases and operations mature.
Bear case
Increased competition and regulatory pressures could erode margins and slow growth.
Time horizon
3-5 years
Est. CAGR
15-20%
Entry (qual.)
Consider on dips below 1700 INR for better risk-reward profile
Exit (qual.)
Reassess if P/E expands beyond 65 or growth falls below 10% for consecutive quarters
Overall conviction 75%
Knowledge graph
Executives & sector are live; peers are clickable → their dissection. Institutional holders shown where the exchange publishes them.
Portfolio impact
Enter tickers + weights, then see how LALPATHLAB fits.
Scenario simulator
Simulate a macro shock and see the illustrative impact:
Tailwind for tech & enablers.
Illustrative impact
Medium prob.Directional illustration only — not modelled on this company's actuals. A real simulator needs company financials.
Explain like…
Re-explain LALPATHLAB for a different audience:
Pick a persona to get a tailored explanation.
Sensai publishes educational market commentary, not investment advice. We are not SEBI-registered investment advisers or research analysts, and nothing here is a recommendation to buy, sell, or hold any security.
Live prices, index levels, and other market data are pulled from third-party feeds, may be delayed, and can be inaccurate or unavailable. Do not rely on them for trading decisions.
Investing in equities carries risk, including the loss of principal. Always do your own research and consider consulting a SEBI-registered adviser before making any investment decision.
Hidden opportunities
Watch next
The stock is attractive for long-term investors despite its premium valuation, given its strong growth trajectory and market position.
simplywall.st·2d ago·missed earnings
TradingView·5d ago·revenue breakdown
TradingView·6d ago·strong growth margins
TradingView·6d ago·double-digit growth
TradingView·6d ago·revenue profit growth
TradingView·6d ago·weekly outlook
Equitypandit·6d ago·earnings report
Real press coverage from the last 7 days, scored by AI for tone — click any headline for the source. This is news sentiment, not social: X / Reddit / Telegram scoring needs a paid social provider. Educational only.
Annual income statement, oldest → newest. Live via Yahoo.
9.005 vs 9.03818
-0.37% surprise
| 17.56% |
| 11.42% |
| 14.60% |
| ABBOTINDIA | 589.56B | 37.95 | 34.46% | 27.02% | 6.50% |
Peers via Yahoo's similarity graph, same-sector first; fundamentals live. Ask the AI copilot below for a qualitative head-to-head.
Support (day/52w low)
₹1,802.00
Resistance (day/52w high)
₹1,893.60
Volume
10,40,059
Trend
up
RSI (14)
75
MACD
bullish
MA cross
golden
50-day MA
₹1,654.28
200-day MA
₹1,502.15
vs 200-DMA
25.3%
RSI/MACD computed from 6 months of daily closes; moving averages from Yahoo. Options positioning still needs an options feed.